Skip to main content
Clinical Trials/CTRI/2023/04/051677
CTRI/2023/04/051677Not yet recruitingPhase 3

Efficacy Of Shigru-Haridradi Aschyotana (Eye Drop) with Haridrakhanda and Bilvadi Aschyotana with Haridrakhanda in the Management of Vataja Abhishyanda (Simple Allergic Conjunctivitis) - An Open Labelled Randomized Comparative Clinical Trial.

Institute of Teaching and Research in Ayurveda0 sites0 target enrollmentStarted: TBDLast updated:

Trial Snapshot

Phase
Phase 3
Status
Not yet recruiting
Sponsor

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Inclusion Criteria

  • 1.Patients between 18 to 50 years of age.
  • 2.Patients having minimum three symptoms of Simple Allergic Conjunctivitis.

Exclusion Criteria

  • 1.Patients below 18 years and above 50 years of age.
  • 2.Patients having complications of corneal involvement like Marginal Corneal Ulcer, Dacryocystitis, Trachoma, Keratoconjunctivitis sicca, Vernal Keratoconjunctivitis, Giant papillary conjunctivitis, Atopic Keratoconjunctivitis.
  • 3.All types of Conjunctivitis (Acute and Chronic) which are non-allergic in nature are excluded from the Study.

Investigators

Sponsor
Institute of Teaching and Research in Ayurveda

Similar Trials